Topics

Companies Related to "MorphoSys Aktie steigt ftig" [Most Relevant Company Matches] RSS

06:36 EST 20th January 2020 | BioPortfolio

Here are the most relevant search results for "MorphoSys Aktie steigt ftig" found in our extensive corporate database of over 50,000 company records.

Showing "MorphoSys Aktie steigt ftig" Companies, all 5

Relevant

MorphoSys GmbH

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceu...


Biogenesis Ltd

Biogenesis is a recognized leader in the supply of monoclonal and polyclonal antibodies and custom manufacturing services to IVD manufacturers, pharmaceutical companies and life science researchers around the globe. For more than 20 years, these customers have chosen Biogenesis for its quality, reliability, and innovation. Our ongoing commitment to quality products and services is demonstrated by ...

MorphoSys AG,

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceu...


MorphoSys AG

MorphoSys AG, located in Martinsried/Munich, is one of the world's leading biotechnology companies focusing on fully human antibodies. With its unique technologies, MorphoSys is developing the next generation of antibodies, which can be used to treat diseases and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceu...

Probably Relevant

Antibodies by Design

Antibodies by Design uses proven MorphoSys recombinant antibody technology to provide high quality monoclonal antibodies to its customers in record time. The HuCAL GOLD® library contains over 15 billion unique human antibody genes in Fab format. This wealth and diversity of sequences is coupled with proprietary automated screening techniques and advanced data management systems to quickly identif...


More From BioPortfolio on "MorphoSys Aktie steigt ftig"

Quick Search

Corporate Database Quicklinks